Geers, Sarah,Lowinger, Michael,McKelvey, Craig A,Meyer, Robert F,Zhang, Dina
申请号：
NO20083821
公开号：
NO341326B1
申请日:
2008.09.08
申请国别(地区):
NO
年份:
2017
代理人:
摘要：
A pharmaceutical composition comprises (a) a CETP inhibiting compound, or a pharmaceutically acceptable salt thereof； (b) a concentration-enhancing polymer, and (c) optionally one or more surfactants； wherein the compound has the structure shown as Formula I below. The composition raises HDL-cholesterol and lowers LDL-cholesterol.
